United Therapeutics Corporation:企業の戦略・SWOT・財務情報

【英語タイトル】United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(DATA904C4467)・商品コード:DATA904C4467
・発行会社(調査会社):MarketLine
・発行日:2018年8月
・ページ数:44
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

United Therapeutics Corporation – Strategy, SWOT and Corporate Finance Report
Summary

United Therapeutics Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

United Therapeutics Corporation (United Therapeutics or ‘the company’) is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life threatening conditions. The product portfolio of the company includes Remodulin Injection; Tyvaso (treprostinil) Inhalation Solution; Adcirca (tadalafil) Tablets; Orenitram (treprostinil) extended release tablets; PLX Cells; Replacement Lungs- Transplantation and Self-Injectable Prostacyclin Analogues- PAH. United Therapeutics sells its products through specialty pharmaceutical distributors in the US. The company operates in Europe, Israel and the Middle East, Asia and South and Central America. United Therapeutics is headquartered in Silver Spring, Maryland, the US.

Scope

- Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
- An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
- Intelligence on United Therapeutics Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of United Therapeutics Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on United Therapeutics Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
United Therapeutics Corporation: Company Overview 9
United Therapeutics Corporation: Overview and Key Facts 9
United Therapeutics Corporation: Overview 9
United Therapeutics Corporation: Key Facts 9
United Therapeutics Corporation: Key Employees 10
United Therapeutics Corporation: Key Employee Biographies 11
United Therapeutics Corporation: Major Products and Services 12
United Therapeutics Corporation: Company History 13
United Therapeutics Corporation: Management Statement 16
United Therapeutics Corporation: Locations and Subsidiaries 19
United Therapeutics Corporation: Key Competitors 20
United Therapeutics Corporation: Company Analysis 21
United Therapeutics Corporation: Business Description 21
United Therapeutics Corporation: SWOT Analysis 23
United Therapeutics Corporation: SWOT Overview 23
United Therapeutics Corporation: Strengths 23
United Therapeutics Corporation: Weaknesses 24
United Therapeutics Corporation: Opportunities 24
United Therapeutics Corporation: Threats 25
United Therapeutics Corporation: Corporate Financial Deals Activity 27
United Therapeutics Corporation: Financial Deals Overview 27
United Therapeutics Corporation: Targets and Partners 29
United Therapeutics Corporation: Top Deals 2014 – 2018YTD* 30
United Therapeutics Corporation: Advisors 31
United Therapeutics Corporation: Top Legal Advisors 31
United Therapeutics Corporation: Mergers and Acquisitions 32
United Therapeutics Corporation: Corporate Venturing 33
United Therapeutics Corporation: Partnership 34
United Therapeutics Corporation: Recent Developments 35
United Therapeutics Corporation: News and Events Summary 35
United Therapeutics Corporation: Corporate Governance 37
United Therapeutics Corporation: Financial Deals 38
United Therapeutics Corporation: Financial Performance 38
United Therapeutics Corporation: Grants 40
United Therapeutics Corporation: Market Developments 40
United Therapeutics Corporation: Regulatory and Legal Events 41
United Therapeutics Corporation: Research & Development 41
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: United Therapeutics Corporation: Key Facts
Table 2: United Therapeutics Corporation: Key Employees
Table 3: United Therapeutics Corporation: Locations and Subsidiaries
Table 4: United Therapeutics Corporation: Key Competitors
Table 5: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
Table 7: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Table 9: United Therapeutics Corporation: Targets and Partners
Table 10: United Therapeutics Corporation: Top Deals 2014 - 2018YTD*
Table 11: United Therapeutics Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: United Therapeutics Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: United Therapeutics Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 14: United Therapeutics Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: United Therapeutics Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: United Therapeutics Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: United Therapeutics Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: United Therapeutics Corporation: News and Events Summary
Table 19: United Therapeutics Corporation: Corporate Governance
Table 20: United Therapeutics Corporation: Financial Deals
Table 21: United Therapeutics Corporation: Financial Performance
Table 22: United Therapeutics Corporation: Grants
Table 23: United Therapeutics Corporation: Market Developments
Table 24: United Therapeutics Corporation: Regulatory and Legal Events
Table 25: United Therapeutics Corporation: Research & Development

List of Figures
Figure 1: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
Figure 3: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: United Therapeutics Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: United Therapeutics Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: United Therapeutics Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: United Therapeutics Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: United Therapeutics Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: United Therapeutics Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★調査レポート[United Therapeutics Corporation:企業の戦略・SWOT・財務情報] (コード:DATA904C4467)販売に関する免責事項を必ずご確認ください。
★調査レポート[United Therapeutics Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆